Deals

AstraZeneca to invest $2.5 bn in new R&D centre, biotech agreements and manufacturing in Beijing

Read more

Syngene concludes acquisition of Emergent BioSolutions’ biologics manufacturing facility

Read more

Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension

Read more

Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset

Read more

Peptris Technologies out-licenses AI-discovered drug candidate to Revio Therapeutics

Read more

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition

Read more

India and Belgium unite to advance RNA-based vaccines

Read more

Senores Pharma acquires 14 ANDAs from Dr. Reddy’s

Read more

Sun Pharma subsidiary Taro acquires Antibe Therapeutics

Read more

Deal value declined by 86.4 per cent in Dec 2024, compared to Dec 2023

Read more